There’s still money to be raised by gene therapy startups with good clinical data. On Wednesday, North Carolina biotech Atsena Therapeutics said it had raised… Read More
Atsena Therapeutics’ $150 million fundraise is a light of hope for the gene therapy field, which has suffered enormously in recent months. Atsena Therapeutics has… Read More
Strong investor syndicate backs clinical-stage Hepatitis B program while advancing pioneering gene-tuning platform DURHAM, N.C. & SEATTLE–(BUSINESS WIRE)–Leading epigenome editing company Tune Therapeutics… Read More
Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary disease (COPD) patients AER-01-002 is well powered… Read More
Funding to Advance New Histotripsy Applications and Launch Innovative BOOMBOX Master Study HistoSonics Edison® Histotripsy System (Photo: Business Wire)… Read More
Oversubscribed financing led by strategic investor, with participation from new and existing investors MINNEAPOLIS, June 25, 2024 /PRNewswire/ — Endogenex, a clinical-stage medical device company dedicated to… Read More
Hatteras Venture Partners’ Clay Thorp describes the growth of North Carolina’s biotech industry during his firm’s 20+ years of experience, and describes what the region… Read More
The NACD Research Triangle Chapter, together with RTI International, is delighted to announce a fellowship award in honor of Robert A. Ingram, acknowledging his exceptional… Read More
Acquisition brings access to a novel investigational ß-lactamase inhibitor, expanding pipeline of critically needed antimicrobials, and further augments R&D capabilities and expertise OSAKA, Japan, June… Read More
Financing accelerates MT-302, the Company’s first clinical candidate for in vivo cell programming, into a Phase 1/2 clinical trial for TROP2+ solid tumors CAMBRIDGE,… Read More